A prospective single-blind study of the impact of perioperative glycemic control using artificial pancreas on the prevention of postoperative complications after abdominal surgery

A prospective single-blind study of the impact of perioperative glycemic control using artificial pancreas on the prevention of postoperative complications after abdominal surgery - A prospective study of the impact of perioperative glycemic control using artificial pancreas on the postoperative complications

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000034304

Enrollment

120

Registered

2018-10-05

Start date

2018-10-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal tumor, Hepatobiliary pancreatic tumor

Interventions

Glycemic control using artificial pancreas 24 hours from the start of surgery Target blood glucose range:140-180 mg/dl Glycemic control using artificial pancreas 24 hours from the start of surgery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Performance status : 0-1 Laparotomy surgery case

Exclusion criteria

Exclusion criteria: Case of serious organ injury Patient whose life prognosis can not be expected for more than 1 month

Design outcomes

Primary

Measure	Time frame
Incidence of infectious complications (30 days after surgery)	—

Secondary

Measure	Time frame
1) perioperative glycemic variability 2) inflammation-related factors 3) insulin resistance, Insulin secretory capacity	—

Countries

Japan

Contacts

Public ContactMiki Nagase

Shiga University of Medical Science Department of Comprehensive Surgery

n12m23@belle.shiga-med.ac.jp0748-22-0873

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026